Back
Legend Biotech Vs. BioCryst Pharmaceuticals Industry Stock Comparison
Sell
16
LEGN
Legend Biotech
Last Price:
44.29
Seasonality Move:
-6.12%
Sell
33
BCRX
BioCryst Pharmaceuticals
Last Price:
8.36
Seasonality Move:
8.43%
Sell
16
Legend Biotech (LEGN)
is a Sell
Is Legend Biotech a Buy, Sell or Hold?
- The current Legend Biotech [LEGN] share price is $45.46. The Score for LEGN is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- LEGN is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
33
BioCryst Pharmaceuticals (BCRX)
is a Sell
Is BioCryst Pharmaceuticals a Buy, Sell or Hold?
- The current BioCryst Pharmaceuticals [BCRX] share price is $8.11. The Score for BCRX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- BCRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LEGN Stock Price Chart
What is Legend Biotech's stock price today?
-
The Legend Biotech share price today is $45.46
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LEGN is experiencing slight buying pressure.
BCRX Stock Price Chart
What is BioCryst Pharmaceuticals's stock price today?
-
The BioCryst Pharmaceuticals share price today is $8.11
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BCRX is experiencing slight buying pressure.
LEGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.46 | Sell |
| Relative Strength Index (14 RSI): | 44.93 | Sell |
| Chaikin Money Flow: | 226386 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.3 - 49.06) | Sell |
| Bollinger Bands (100): | (44.97 - 55.87) | Sell |
BCRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 60.23 | Buy |
| Chaikin Money Flow: | 279537 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.32 - 7.9) | Buy |
| Bollinger Bands (100): | (6.72 - 8.06) | Buy |
LEGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.36 | Buy |
| 20-day SMA: | 46.66 | Sell |
| 50-day SMA: | 50.05 | Sell |
| 200-day SMA: | 52.31 | Sell |
| 8-day EMA: | 45.09 | Buy |
| 20-day EMA: | 46.3 | Sell |
| 50-day EMA: | 48.62 | Sell |
| 200-day EMA: | 52.33 | Sell |
BCRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.94 | Buy |
| 20-day SMA: | 7.61 | Buy |
| 50-day SMA: | 7.83 | Buy |
| 200-day SMA: | 6.38 | Buy |
| 8-day EMA: | 7.95 | Buy |
| 20-day EMA: | 7.78 | Buy |
| 50-day EMA: | 7.66 | Buy |
| 200-day EMA: | 6.98 | Buy |
Legend Biotech Earnings Growth & LEGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.42 per share, and an increase next year of $0.73 per share.
BioCryst Pharmaceuticals Earnings Growth & BCRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.67 per share, and an increase next year of $0.24 per share.
Legend Biotech Technical Analysis
| Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
BioCryst Pharmaceuticals Technical Analysis
| Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||